CLWFX
Price
$91.58
Change
-$0.35 (-0.38%)
Updated
Jun 2 closing price
Net Assets
7.02B
RGACX
Price
$85.14
Change
-$0.28 (-0.33%)
Updated
Jun 2 closing price
Net Assets
337.53B
Interact to see
Advertisement

CLWFX vs RGACX

Header iconCLWFX vs RGACX Comparison
Open Charts CLWFX vs RGACXBanner chart's image
CLWFX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
CLWFX vs. RGACX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLWFX is a Hold and RGACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 338B vs. CLWFX (7.02B). CLWFX (0.00) and RGACX (0.00) have matching dividends . CLWFX was incepted earlier than RGACX: CLWFX (15 years) vs RGACX (24 years). RGACX (0.93) is less costly to investors than CLWFX (0.70). CLWFX is a more actively managed with annual turnover of: 48.00 vs. RGACX (32.00). CLWFX has a lower initial minimum investment than RGACX: CLWFX (0) vs RGACX (250). CLWFX annual gain was more profitable for investors over the last year : 21.12 vs. RGACX (14.24). CLWFX return over 5 years is better than : 53.75 vs. RGACX (22.53).
CLWFXRGACXCLWFX / RGACX
Total Expense Ratio0.700.9375%
Annual Report Gross Expense Ratio0.700.9375%
Fund Existence15 years24 years-
Gain YTD11.74210.291114%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets7.02B338B2%
Annual Yield % from dividends0.000.00-
Returns for 1 year21.1214.24148%
Returns for 3 years65.3751.07128%
Returns for 5 years53.7522.53239%
Returns for 10 years170.35107.79158%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DBISX12.04N/A
N/A
DWS Global Macro A
MNNCX37.74N/A
N/A
Victory Multi-Cap C
ATHIX26.39N/A
N/A
American Century Heritage I
USSCX40.40N/A
N/A
Victory Science & Technology
GWILX8.94N/A
N/A
Glenmede SMID Core Equity Advisor